Fig. 6From: Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolitesThe random forest model based on the microbiota and metabolites to assess the candidate biomarkers. (A) Individual ROC curves for Stearoylethanolamide, Serylthreonine, Xestoaminol C and Farnesyl acetone. (B) ROC curves for the combination of the four metabolites. (C) ROC analysis of the combination of gut microbes and metabolitesBack to article page